PMP2 (Peripheral Myelin Protein 2)

A key component of peripheral nervous system myelin, involved in Charcot-Marie-Tooth disease and other neuropathies.

Gene Information Card

Symbol PMP2
Full Name Peripheral Myelin Protein 2
Gene Type protein-coding
Chromosomal Location 8q21.13
NCBI Gene ID 5375 ncbi.nlm.nih.gov/gene/5375
Ensembl ID ENSG00000147588
UniProt ID P02689
OMIM ID 170715
HGNC ID 9117
Aliases MGC116750, MGC116751, myelin P2 protein

Description

The PMP2 gene encodes peripheral myelin protein 2 (P2), a small cytoplasmic protein that binds fatty acids and is a major structural component of peripheral nerve myelin. It is involved in myelin compaction and lipid transport in Schwann cells. Mutations in PMP2 cause Charcot-Marie-Tooth disease type 1G (CMT1G), a demyelinating peripheral neuropathy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Charcot-Marie-Tooth disease type 1G (CMT1G) Loss-of-function mutations in PMP2 disrupt myelin compaction and lipid binding, leading to peripheral nerve demyelination and axonal loss. ClinVar, OMIM
Charcot-Marie-Tooth disease type 2 (axonal) Some PMP2 variants are associated with axonal neuropathy, though the mechanism is less clear. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Peripheral nerve High High
Spinal cord Moderate Medium
Brain (cerebellum) Low Low
Adipose tissue Low Low
Cell Line Expression
Cell Line nTPM Notes
Schwann cells High Primary cell type expressing PMP2
SHSY5Y (neuroblastoma) Low Neuronal cell line
HEK293 Not detected Non-neuronal cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.435C>A (p.Tyr145*) Nonsense Rare Loss of function; associated with CMT1G
c.380G>A (p.Arg127His) Missense Rare Impaired lipid binding; associated with CMT1G
c.2T>C (p.Met1Thr) Missense Rare Loss of start codon; loss of function
Mutation functional classification

Loss of Function (LOF)

Nonsense and missense mutations that reduce or abolish protein expression or lipid-binding activity lead to demyelinating neuropathy (CMT1G).

Gain of Function (GOF)

No gain-of-function mutations have been reported for PMP2.

Dominant Negative (DN)

Some missense variants may exert a dominant-negative effect by interfering with myelin compaction, though evidence is limited.

Pathways

KEGG: hsa04721 - Synaptic vesicle cycle (indirect)
Reactome: R-HSA-1474244 - Extracellular matrix organization (indirect)

Protein Summary

Peripheral myelin protein 2 (P2) is a 132-amino acid cytoplasmic protein expressed in Schwann cells. It belongs to the fatty acid-binding protein (FABP) family and is essential for myelin compaction and lipid homeostasis in peripheral nerves. The protein adopts a beta-barrel structure that binds long-chain fatty acids. Mutations in PMP2 cause Charcot-Marie-Tooth disease type 1G, a progressive demyelinating neuropathy.

Related Products

Product name Cat.No. Species Gene ID
PMP2 Knockout HEK293 Cell Line EDJ-KQ5495 Human 5375 Details Get a Quote
PMP22 Knockout HEK293 Cell Line EDJ-KQ5496 Human 5376 Details Get a Quote
PMP22 Knockout A-549 Cell Line EDJ-KQ28728 Human 5376 Details Get a Quote
PMP22 Knockout HCT 116 Cell Line EDJ-KQ28729 Human 5376 Details Get a Quote
PMP22 Knockout HeLa Cell Line EDJ-KQ28730 Human 5376 Details Get a Quote
PMP2 Knockout HeLa Cell Line EDJ-KQ54164 Human 5375 Details Get a Quote
PMP2 Knockout A-549 Cell Line EDJ-KQ62660 Human 5375 Details Get a Quote
PMP2 Knockout HCT 116 Cell Line EDJ-KQ71127 Human 5375 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: